Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21704046rdf:typepubmed:Citationlld:pubmed
pubmed-article:21704046lifeskim:mentionsumls-concept:C0011503lld:lifeskim
pubmed-article:21704046lifeskim:mentionsumls-concept:C0030011lld:lifeskim
pubmed-article:21704046lifeskim:mentionsumls-concept:C1514468lld:lifeskim
pubmed-article:21704046lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:21704046lifeskim:mentionsumls-concept:C0287887lld:lifeskim
pubmed-article:21704046pubmed:issue1-2lld:pubmed
pubmed-article:21704046pubmed:dateCreated2011-8-25lld:pubmed
pubmed-article:21704046pubmed:abstractText8-Oxo-7,8-dihydroguanine (8-hydroxyguanine) is oxidized more easily than normal nucleobases, which can produce spiroiminodihydantoin (Sp) and guanidinohydantoin (Gh). These secondary oxidation products of 8-oxo-7,8-dihydroguanine are highly mutagenic when formed within DNA. To evaluate the mutagenicity of the corresponding oxidation products of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-hydroxy-2'- deoxyguanosine 5'-triphosphate) in the nucleotide pool, Escherichia coli cells deficient in the mutT gene were treated with H(2)O(2), and the induced mutations were analyzed. Moreover, the 2'-deoxyriboside 5'-triphosphate derivatives of Sp and Gh were also introduced into competent E. coli cells. The H(2)O(2) treatment of mutT E. coli cells resulted in increase of G:C ? T:A and A:T ? T:A mutations. However, the incorporation of exogenous Sp and Gh 2'-deoxyribonucleotides did not significantly increase the mutation frequency. These results suggested that the oxidation product(s) of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate induces G:C ? T:A and A:T ? T:A mutations, and that the 2'-deoxyriboside 5'-triphosphate derivatives of Sp and Gh exhibit quite weak mutagenicity, in contrast to the bases in DNA.lld:pubmed
pubmed-article:21704046pubmed:languageenglld:pubmed
pubmed-article:21704046pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:citationSubsetIMlld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21704046pubmed:statusMEDLINElld:pubmed
pubmed-article:21704046pubmed:monthSeplld:pubmed
pubmed-article:21704046pubmed:issn0027-5107lld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:KamiyaHiroyuk...lld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:MatsudaAkiraAlld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:SuzukiTetsuya...lld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:MinakawaNoria...lld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:HarashimaHide...lld:pubmed
pubmed-article:21704046pubmed:authorpubmed-author:HoriMikaMlld:pubmed
pubmed-article:21704046pubmed:copyrightInfoCopyright © 2011 Elsevier B.V. All rights reserved.lld:pubmed
pubmed-article:21704046pubmed:issnTypePrintlld:pubmed
pubmed-article:21704046pubmed:day1lld:pubmed
pubmed-article:21704046pubmed:volume714lld:pubmed
pubmed-article:21704046pubmed:ownerNLMlld:pubmed
pubmed-article:21704046pubmed:authorsCompleteYlld:pubmed
pubmed-article:21704046pubmed:pagination11-6lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:meshHeadingpubmed-meshheading:21704046...lld:pubmed
pubmed-article:21704046pubmed:year2011lld:pubmed
pubmed-article:21704046pubmed:articleTitleMutagenicity of secondary oxidation products of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-hydroxy-2'- deoxyguanosine 5'-triphosphate).lld:pubmed
pubmed-article:21704046pubmed:affiliationFaculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.lld:pubmed
pubmed-article:21704046pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21704046pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed